Fangchinoline inhibits rat aortic vascular smooth muscle cell proliferation and cell cycle progression through inhibition of ERK1/2 activation and c-fos expression

Biochemical Pharmacology

Volumn 66, Issue 9, 2003, Pages 1853-1860

  Zhang, Yong He ^a   Fang, Lian Hua ^b   Ku, Bao Shan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Aortic smooth muscle cells; c fos; Cell cycle; Fangchinoline; MAP kinase; Proliferation

Indexed keywords

BOVINE SERUM ALBUMIN; DNA; FANGQUINOLINE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN C FOS; THYMIDINE;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE;

EID: 0141992028     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00550-1     Document Type: Article

References (25)

1. Ross R. The pathogenesis of arteriosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
2. Schwartz S. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest. 99:1997;2814-2846.
3. Cobb M.H., Boulton T.G., Robbins D.J. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul. 2:1991;965-978.
4. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
5. Gille H., Sharrocks A.D., Shaw P.E. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at the c-fos promoter. Nature. 358:1992;414-417.
6. Hu XM. Complete works of secret recipe of Chinese traditional medicine. Shaghai, China: Wenhui Publishing House; 1994. p. 268.
7. Nakamura K., Tsuchiya S., Sugimoto Y., Sugimura Y., Yamada Y. Histamine release inhibition activity of bisbenzylisoquinoline alkaloids. Planta Med. 58:1992;505-508.
8. Kim H.S., Zhang Y.H., Oh K.W., Ahn H.Y. Vasodilating and hypotensive effects of fangchinoline and tetrandrine on the rat aorta and the stroke-prone spontaneously hypertensive rat. J. Ethnopharmacol. 58:1997;117-123.
9. Jin Q., Kang C., Soh Y., Sohn N.W., Lee J., Cho Y.H., Baik H.H., Kang I. Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells. Life Sci. 71:2002;2053-2066.
10. Wang H.L., Kilfeather S.A., Martin G.R., Page C.P. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulm. Pharmacol. Ther. 13:2000;53-60.
11. Kim H.S., Zhang Y.H., Yun Y.P. Effects of tetrandrine and fangchinoline on the experimental thrombosis in mice and human platelet aggregation. Planta Med. 65:1999;135-138.
12. Chamley J.H., Campbell G.R., McConnell J.D., Groschel-Stewart U. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res. 177:1977;503-522.
13. Zhang Y.H., Park Y.S., Kim T.J., Fang L.H., Ahn H.Y., Hong J.T., Kim Y.S., Lee C.K., Yun Y.P. Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin. Gen. Pharmacol. 35:2002;341-347.
14. Bradford H.M. A rapid sensitive method for quantitation of microgram quantities of protein utilizing the principle protein-dye binding. Anal. Biochem. 72:1976;248-254.
15. Kim T.J., Zhang Y.H., Kim Y.S., Lee C.K., Lee M.K., Hong J.T., Yun Y.P. Effects of apigenin on the serum- and platelet-derived growth factor-BB-induced ERK1/2, c-fos mRNA and proliferation of rat aortic vascular smooth muscle cells. Planta Med. 68:2002;605-609.
16. Waller B.F., Pinkerton C.A., Orr C.M., Slack J.D., VanTassel J.W., Peters T. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty. Circulation. 83(Suppl. 2):1991;I28-I41.
17. Nagata N., Niwa Y., Nakaya Y. A novel 31-amino-acid-length endothelin, ET-1(1-31), can act as a biologically active peptide for vascular smooth muscle cells. Biochem. Biophys. Res. Co. 275:2000;595-600.
18. Kondo T.F., Konishi T., Inagami T. Differing signal transductions elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells. J. Biol. Chem. 268:1993;4458-4464.
19. Jiang B., Yamamura S., Nelson P.R., Mureebe L., Kent K.C. Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery. 120:1996;427-432.
20. Kakishita H., Hattori Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sci. 69:2001;689-697.
21. 2+ influx and cell proliferation in rat aortic smooth muscle cell lines. Eur. J. Pharmacol. 379:1999;199-209.
22. Wu S.N., Hwang T.L., Jan C.R., Tseng C.J. Ionic mechanisms of tetrandrine in cultured rat aortic smooth muscle cells. Eur. J. Pharmacol. 327:1997;233-238.
23. 2+ current. Brain Res. 812:1998;133-141.
24. Rozengurt E. Early signals in the mitogenic response. Science. 234:1986;161-166.
25. Graf K., Xi X.P., Yang D., Fleck E., Hsueh W.A., Law R.E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:1997;334-339.